GPO ramps up domestic antiviral production following shortage concerns

The Government Pharmaceutical Organization is expected to produce Favipiravir antiviral medication for COVID-19 treatment of more than 40 million tablets per month from October onwards, following concerns raised by hospitals on potential shortages. The Government Pharmaceutical Organization (GPO) has revealed its expected production yield of locally produced Favipiravir is 2.5 million tablets in August, 23 […]

Read More Read More

GPO denies overcharging for Moderna jabs

The Government Pharmaceutical Organization (GPO), insisted today that the price per-dose of the Moderna vaccine it plans to sell to private hospitals, reflects actual costs, dismissing allegations of overcharging. The Government Pharmaceutical Organization (GPO) has also released a statement in which it responds to allegations the organization is overcharging private hospitals buying the Moderna vaccine. […]

Read More Read More